Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析

◆英語タイトル:Bionomics Ltd (BNO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61979FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer’s disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among others. It uses various technology platforms including multicore; ionX; and CSC Rx Discovery platform for discovering highly active, functional therapeutic antibodies and small molecule candidates that target cancer stem cells, among others. Bionomics’ ionX includes systems for high throughput electrophysiology for early and high content evaluation of drug hits. The company conducts clinical studies including post-traumatic stress disorder study, multiple ascending dose study, and generalized anxiety disorder study, dose esclaltion study. Bionomics is headquartered in Thebarton, South Australia, Australia.

Bionomics Ltd Key Recent Developments

Feb 17,2021: Joint feasibility assessment of Bionomics’ BNC210 and EmpathBio’s MDMA derivative EMP-01 treatment regimen for PTSD
Oct 13,2020: Bionomics receives R&D tax incentive refund for FY2020 of $2.9M
Sep 24,2020: Bionomics: Appointment of two new directors
Jul 03,2020: Bionomics: Appointment of new director – Mr Aaron Weaver

This comprehensive SWOT profile of Bionomics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bionomics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Bionomics Ltd – Key Information
Bionomics Ltd – Overview
Bionomics Ltd – Key Employees
Bionomics Ltd – Key Employee Biographies
Bionomics Ltd – Key Operational Heads
Bionomics Ltd – Major Products and Services
Bionomics Ltd – History
Bionomics Ltd – Company Statement
Bionomics Ltd – Locations And Subsidiaries
Bionomics Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Bionomics Ltd – Business Description
Bionomics Ltd – Corporate Strategy
Bionomics Ltd – SWOT Analysis
SWOT Analysis – Overview
Bionomics Ltd – Strengths
Bionomics Ltd – Weaknesses
Bionomics Ltd – Opportunities
Bionomics Ltd – Threats
Bionomics Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Bionomics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Bionomics Ltd, Key Information
Bionomics Ltd, Key Ratios
Bionomics Ltd, Share Data
Bionomics Ltd, Major Products and Services
Bionomics Ltd, History
Bionomics Ltd, Key Employees
Bionomics Ltd, Key Employee Biographies
Bionomics Ltd, Key Operational Heads
Bionomics Ltd, Other Locations
Bionomics Ltd, Subsidiaries
Bionomics Ltd, Key Competitors
Bionomics Ltd, SWOT Analysis
Bionomics Ltd, Ratios based on current share price
Bionomics Ltd, Annual Ratios
Bionomics Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • S. Kumars Nationwide Ltd:企業の戦略・SWOT・財務情報
    S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report Summary S. Kumars Nationwide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • Wanbury Ltd (WANBURY):企業の財務・戦略的SWOT分析
    Summary Wanbury Ltd (Wanbury) is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients. The company offers products such as Cpink tablet, rabiplus capsule, cdense tablets, gems, folinine softule, adtrol-plus soft gelatin capsule, cheer capsule and cheer syrup. It inc …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析
    Summary Merit Medical Systems Inc (Merit Medical) offers a range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic cathe …
  • Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Zafgen Inc (ZFGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Pinnacle Entertainment Inc:企業のM&A・事業提携・投資動向
    Pinnacle Entertainment Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pinnacle Entertainment Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Colbun SA:発電所・企業SWOT分析
    Colbun SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • QIAGEN N.V.:企業の戦略・SWOT・財務情報
    QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report Summary QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Heron Therapeutics Inc (HRTX)-医療機器分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • Ahli Bank Qsc:企業の戦略・SWOT・財務分析
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Shinva Medical Instrument Co Ltd (600587):企業の財務・戦略的SWOT分析
    Shinva Medical Instrument Co Ltd (600587) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Exxon Mobil Corp (XOM):電力:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Navamedic ASA (NAVA):企業の財務・戦略的SWOT分析
    Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Strategic Resources Inc (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Genesis Energy Limited:企業の戦略・SWOT・財務分析
    Genesis Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆